Analysis

Biotechs Turn To Licensing, Collaboration Deals For Capital

By Yeji Jesse Lee · April 16, 2024, 2:15 PM EDT

Biotech companies are turning to licensing and collaboration deals amid a tough public market and larger economic slowdown....

To view the full article, register now.